Company

Lycia Therapeutics

https://lyciatx.com/

Industrydeveloper of extracellular protein degradation and lysosomal targeting chimera (LYTAC) therapeutics

Funding raised

CompanyRoundDate
Lycia TherapeuticsSeries D2026-06-29